Greater Boston Consortium on Pathogen Readiness: Evergrande COVID-19 Response Fund Awards Deadlines

Greater Boston Consortium on Pathogen Readiness: Evergrande COVID-19 Response Fund Awards
Deadline: March 24, 2020 by 5:00PM
Award Amount: $50,000 to $500,000 per project for a maximum duration of 2 years
Note: A signature from an institutional authorized official is not required at this stage of the process. If your proposal is prioritized for funding, the PI will work with their grants manager to present a final budget with institutional assurances and signatures.
PI Limits: A PI may serve as Lead PI on one proposal only; there are no limits on serving as a Co-PI

Harvard Medical School (HMS) is now accepting applications for the Evergrande COVID-19 Response Fund Awards, available through the Greater Boston Consortium on Pathogen Readiness (GBCPR). The response fund will address critical needs raised by this outbreak and will involve research activities on all aspects of COVID-19 disease, including:

• Research to understand disease epidemiology and modeling (including analyses of acute public health responses)
• Research to elucidate the pathogenesis of the disease
• Research to develop rapid diagnostic tools (especially novel tools that are not currently represented in the world’s diagnostics armamentarium)
• Research to develop small molecule and antibody therapeutics
• Research to develop vaccines
• Research to improve the clinical management of the disease

All research approaches will be considered, from classical laboratory approaches to artificial intelligence applications and more. Preference will be given to projects that are directly applicable to address the current, urgent needs of the COVID-19 outbreak.

Tenure-track faculty members at the level of Assistant Professor, Associate Professor, or Full Professor at Harvard University (HMS, FAS, HCSPH, HSDM, SEAS), MIT, Boston University School of Medicine, Tufts University School of Medicine, University of Massachusetts Medical School, and hospitals and research institutes affiliated with these medical schools are eligible to apply as Lead PI. Proposals may include one or more Co-PI collaborators who will contribute to the intellectual development of the project, design studies or parts thereof, and be involved with the project throughout the term of funding. Eligibility requirements for Co-PIs are the same as for the Lead PI. Senior scientists from biotechnology and pharmaceutical companies who meet their firm’s eligibility criteria are also eligible as Co-PIs. There can be a maximum of one Lead PI per proposal. A PI may serve as Lead PI on one proposal only, and may serve as a Co-PI on other proposals as well.